Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chi

Showing results (861-870 of 903) with videos related to

Pageof 91
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancerMario M Leitao, Alexia Iasonos, Morgan Tomberlin, et al.
Gynecologic Oncology|January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide managementYing L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Neuro-Oncology|January 10, 2015
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic gliomaEudocia Q Lee, David A Reardon, David Schiff, et al.
JCO Clinical Cancer Informatics|March 3, 2022
Gynecologic Survivorship Tool: Development, Implementation, and Symptom OutcomesJeanne Carter, Nadeem R Abu-Rustum, Sally Saban, et al.
Oncogenesis|October 25, 2016
GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growthN S Bayin, J D Frenster, J R Kane, et al.
Neuro-Oncology|May 30, 2019
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumorsHui Chen, Cheddhi Thomas, Felipe Andres Munoz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 8, 2025
A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Kimberly Murphy, Kaothar Oladoja, et al.
Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.
Gynecologic Oncology|November 30, 2019
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomyMario M Leitao, Qin C Zhou, Natalia R Gomez-Hidalgo, et al.
Pageof 91

Showing results (861-870 of 903) with videos related to

Sort By:
Pageof 91
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancerMario M Leitao, Alexia Iasonos, Morgan Tomberlin, et al.
Gynecologic Oncology|January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide managementYing L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T Curry, et al.
Neuro-Oncology|January 10, 2015
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic gliomaEudocia Q Lee, David A Reardon, David Schiff, et al.
JCO Clinical Cancer Informatics|March 3, 2022
Gynecologic Survivorship Tool: Development, Implementation, and Symptom OutcomesJeanne Carter, Nadeem R Abu-Rustum, Sally Saban, et al.
Oncogenesis|October 25, 2016
GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growthN S Bayin, J D Frenster, J R Kane, et al.
Neuro-Oncology|May 30, 2019
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumorsHui Chen, Cheddhi Thomas, Felipe Andres Munoz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 8, 2025
A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Kimberly Murphy, Kaothar Oladoja, et al.
Cancer Discovery|August 21, 2014
Brain tumor cells in circulation are enriched for mesenchymal gene expressionJames P Sullivan, Brian V Nahed, Marissa W Madden, et al.
Gynecologic Oncology|November 30, 2019
Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomyMario M Leitao, Qin C Zhou, Natalia R Gomez-Hidalgo, et al.
Pageof 91